Advanced diagnostic and prognostic solutions for urological cancer care 

No matter which test(s) you receive from our growing portfolio of traditional and breakthrough products and services, rest assured they are backed by our superior clinical expertise and the
highest level of customer support.

Press Release

Metamark Announces Appointment of Dr. Peter Blume-Jensen to its Scientific Advisory Board

Metamark today announced that its Chief Scientific Officer, Peter Blume-Jensen, M.D., Ph.D., will be joining a targeted therapeutics startup, and will continue working for Metamark as a member of the company’s Scientific Advisory Board and as a consultant.

read article
Press Release

New Data Demonstrates ProMark™ Accurately Predicts Prostate Cancer Aggressiveness and Pathological Outcomes

ProMark™ has Potential to Transform Prostate Cancer Care by Aiding Doctors and Patients with Appropriate Treatment Assessment

read article
Displaying results 11-12 (of 13)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7  >  >|